| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |